Congenital heart defect (CHD)-related telehealth and other outpatient utilization among Medicaid and private insurance beneficiaries: 2018-2023.

Among adults and children in both insured populations, congenital heart defects-related outpatient utilization increased before the COVID-19 interruption (January 2018-February 2020); afterward, it decreased in Medicaid but continued increasing at a slower rate among the privately-insured (all P < 0.01).

For children, congenital heart defects-related outpatient utilization in June 2020 was lower (8%-Medicaid, 5%-private) than would be expected without the interruption (both P < 0.01).